PTPedro Paulo Teixeira da Silva Torres

Pedro Paulo Teixeira da Silva Torres

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pedro Paulo Teixeira da Silva Torres has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Rare Case of COPA Syndrome: Multisystem Relapse and Fatal Septic Complication

    by Flavia Castro Velasco Fernandes, Pedro Paulo Teixeira e Silva Torres, Elisângela de Paula Silveira‐Lacerda, Matheus Rabahi, Lucas Velasco Magalhaes Fernandes, Laís Rocha Lopes, Marise Amaral Rebouças Moreira, Marcelo Fouad Rabahi

    COPA syndrome is a rare autosomal dominant autoimmune disorder caused by COPA gene mutations, leading to immune dysregulation and multisystem involvement. We report a 45‐year‐old man with recurrent respiratory failure, haemoptysis, renal dysfunction and arthritis. Symptoms began at Age 27 with diffuse alveolar damage requiring mechanical ventilation. Imaging showed progressive interstitial lung disease and biopsy revealed follicular bronchiolitis. Immunosuppression provided temporary stabilisation. In 2024, next‐generation sequencing confirmed a likely pathogenic COPA variant. The patient later discontinued therapy and remained untreated for 1 year, returning with worsening renal dysfunction and significant proteinuria, while pulmonary findings remained stable. Cyclophosphamide was initiated for suspected renal relapse. During treatment, he developed acute diverticulitis complicated by sepsis, progressing to septic shock and multiorgan failure despite surgery and antibiotics, resulting in death. Early recognition and multidisciplinary management are essential to improve outcomes of the disease.

  • Open Access

    Quantitative Tomographic Analysis as a Prognostic Tool in Connective Tissue Disease-Associated Interstitial Lung Disease

    by Camila Vilas Boas Machado, Pedro Paulo Teixeira da Silva Torres, Danilo Tadao Wada, Francisco Aristofanes Coelho Sarmento Neto, Maria Carolina de Oliveira Rodrigues, Marcel Koenigkam-Santos

    Background/Objectives: Interstitial lung disease (ILD) is the main thoracic manifestation of connective tissue diseases (CTDs) and is associated with high morbidity and mortality. High-resolution computed tomography (HRCT) of the chest is considered the gold standard imaging method for detecting and accurately characterizing ILD. This study aims to perform longitudinal visual and quantitative analyses of HRCT scans of patients with ILD secondary to CTD (ILD-CTD) and to correlate these findings with clinical outcomes (functional decline and death) in order to identify tomographic prognostic markers. Methods: This retrospective and longitudinal study included 195 patients with CTD who underwent HRCT at baseline and after two follow-ups. Data collected included initial disease extent and subjective impression of progression, as well as quantitative parameters such as lung volume and mean lung density. Forced vital capacity (FVC) and diffusion capacity of carbon monoxide (DLCO) values were also recorded, along with information on patient outcome. Results: Quantitative and visual assessments demonstrated moderate agreement in estimating ILD extent. Variations in lung volume, ground-glass index, pulmonary vascular volume-to-lung volume ratio, and disease extent correlated with subjective perception of disease progression. Lung volume reduction and increased disease extent were associated with FVC decrease at follow-up 1, whereas an increased fibrosis index correlated with reduced FVC at follow-up 2. No quantitative parameter was associated with mortality risk. Conclusions: The results support the potential benefit of using quantitative CT analysis as a complementary tool to pulmonary function tests and visual analysis in the longitudinal evaluation of ILD-CTD.


  • Open Access

    Computed tomography imaging features of major pulmonary and extrapulmonary complications of fibrotic lung diseases

    by Pedro Paulo Teixeira e Silva Torres, Paula Terra Martins Almeida Amaral, Alan Diniz Hummel, Eduardo Kaiser Ururahy Nunes Fonseca, Rodrigo Caruso Chate, Gilberto Szarf, Flávia Castro Velasco, Dante Luiz Escuissato, Marcelo Fouad Rabahi, Edson Marchiori

    Patients diagnosed with fibrosing interstitial lung disease are at risk of several complications, some of which may be life-threatening. Computed tomography imaging plays an important role in diagnosing these overlapping conditions. This article summarizes the computed tomography imaging features of the most common conditions associated with fibrosing interstitial lung diseases, categorized by involvement of the lung parenchyma or extra-pulmonary compartments. Some steps may help to recognize such complications, such as having knowledge of the underlying fibrotic lung disease, being

  • Open Access

    Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis

    by Bruno Guedes Baldi, Paulo Henrique Ramos Feitosa, Adalberto Sperb Rubin, Alexandre Franco Amaral, Carolina Salim Gonçalves Freitas, Cláudia Henrique da Costa, Eliane Viana Mancuzo, Ellen Caroline Toledo Do Nascimento, Mariana Sponholz Araujo, Marcelo Jorge Jacó Rocha, et al.

    Lymphangioleiomyomatosis (LAM) is a rare disease, characterized as a low-grade neoplasm with metastatic potential that mainly affects women of reproductive age, in which there is proliferation of atypical smooth muscle cells (LAM cells) and formation of diffuse pulmonary cysts. It can occur in a sporadic form or in combination with tuberous sclerosis complex. In recent decades, a number of advances have been made in the understanding of the pathophysiology and management of LAM, leading to improvements in its prognosis: identification of the main genetic aspects and the role of the mechanistic target of rapamycin (mTOR) pathway; relationship with hormonal factors, mainly estrogen; characterization of pulmonary and extrapulmonary manifestations in imaging studies; identification and importance in the diagnosis of VEGF-D; a systematic diagnostic approach, often without the need for lung biopsy; use of and indications for the use of mTOR inhibitors, mainly sirolimus, for pulmonary and extrapulmonary manifestations; pulmonary rehabilitation and the management of complications such as pneumothorax and chylothorax; and the role of and indications for lung transplantation. To date, no Brazilian recommendations for a comprehensive approach to the disease have been published. This document is the result of a non-systematic review of the literature, carried out by 12 pulmonologists, a radiologist, and a pathologist, which aims to provide an update of the most important topics related to LAM, mainly to its diagnosis, treatment, and follow-up, including practical and multidisciplinary aspects of its management.


  • Open Access

    Pulmonary edema: what can it tell us? A pictorial essay

    by Matheus Marcelino Dias, Eduardo Kaiser Ururahy Nunes Fonseca, Lucas Chagas Aquino, Roberta Castro Linhares, Lavínia Ferreira Dias, Pedro Paulo Teixeira e Silva Torres, Danilo Perussi Bianco, Murilo Marques Silva, Rodrigo Caruso Chate

    Pulmonary edema is a very prevalent condition, especially in the intensive care setting, and can have different origins and be caused by different mechanisms. Imaging tests, particularly computed tomography, are sometimes used in the diagnostic investigation of these patients, and may even help to elucidate the etiology. Therefore, it is essential that radiologists understand the dynamic nature of the changes associated with pulmonary edema and be able to recognize diagnostic clues that indicate possible etiologies, in addition to understanding the underlying mechanisms. This illustrated essay provides a concise review of the pathophysiology of pulmonary edema and highlights its main imaging findings, focusing on the clinical features that help to refine the etiological diagnosis.


  • Open Access

    Edema pulmonar: o que ele pode nos dizer? Um ensaio iconográfico

    by Matheus Marcelino Dias, Eduardo Kaiser Ururahy Nunes Fonseca, Lucas Chagas Aquino, Roberta Castro Linhares, Lavínia Ferreira Dias, Pedro Paulo Teixeira e Silva Torres, Danilo Perussi Bianco, Murilo Marques Silva, Rodrigo Caruso Chate

    Resumo O edema pulmonar é uma condição bastante prevalente, sobretudo no contexto de terapia intensiva, ocasionado por diferentes origens e decorrente de mecanismos diversos. Por vezes, os exames de imagem, em particular a tomografia computadorizada, são utilizados na investigação diagnóstica desses pacientes, podendo auxiliar, inclusive, na elucidação etiológica. Portanto, é essencial que os radiologistas entendam a natureza dinâmica das alterações associadas ao edema pulmonar e sejam capazes de reconhecer pistas diagnósticas que indiquem possíveis etiologias, além de compreender os mecanismos subjacentes. Este ensaio ilustrado oferece uma revisão concisa da fisiopatologia do edema pulmonar e destaca seus principais achados em imagens, enfocando as características clínicas que ajudam a refinar o diagnóstico etiológico.

  • Open Access

    Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging

    by Luiz Fernando Ferreira Pereira, Ricardo Sales Dos Santos, Daniel Oliveira Bonomi, Juliana Franceschini, Ilka Lopes Santoro, André Miotto, Thiago Lins Fagundes de Sousa, Rodrigo Caruso Chate, Bruno Hochhegger, Artur Gomes Neto, et al.

    Although lung cancer (LC) is one of the most common and lethal tumors, only 15% of patients are diagnosed at an early stage. Smoking is still responsible for more than 85% of cases. Lung cancer screening (LCS) with low-dose CT (LDCT) reduces LC-related mortality by 20%, and that reduction reaches 38% when LCS by LDCT is combined with smoking cessation. In the last decade, a number of countries have adopted population-based LCS as a public health recommendation. Albeit still incipient, discussion on this topic in Brazil is becoming increasingly broad and necessary. With the aim of increasing knowledge and stimulating debate on LCS, the Brazilian Society of Thoracic Surgery, the Brazilian Thoracic Association, and the Brazilian College of Radiology and Diagnostic Imaging convened a panel of experts to prepare recommendations for LCS in Brazil. The recommendations presented here were based on a narrative review of the literature, with an emphasis on large population-based studies, systematic reviews, and the recommendations of international guidelines, and were developed after extensive discussion by the panel of experts. The following topics were reviewed: reasons for screening; general considerations about smoking; epidemiology of LC; eligibility criteria; incidental findings; granulomatous lesions; probabilistic models; minimum requirements for LDCT; volumetric acquisition; risks of screening; minimum structure and role of the multidisciplinary team; practice according to the Lung CT Screening Reporting and Data System; costs versus benefits of screening; and future perspectives for LCS.


  • The diagnostic value of magnetic resonance imaging compared to computed tomography in the evaluation of fat-containing thoracic lesions

    by Bruno Hochhegger, Matheus Zanon, Pratik P Patel, Nupur Verma, Diego André Eifer, Pedro Paulo Teixeira e Silva Torres, Arthur S Souza, Luciana Volpon Soares Souza, Tan-Lucien Mohammed, Edson Marchiori, et al.

    Intrathoracic fat-containing lesions may arise in the mediastinum, lungs, pleura, or chest wall. While CT can be helpful in the detection and diagnosis of these lesions, it can only do so if the lesions contain macroscopic fat. Furthermore, because CT cannot demonstrate microscopic or intravoxel fat, it can fail to identify and diagnose microscopic fat-containing lesions. MRI, employing spectral and chemical shift fat suppression techniques, can identify both macroscopic and microscopic fat, with resultant enhanced capability to diagnose these intrathoracic lesions non-invasively and without ionizing radiation. This paper aims to review the CT and MRI findings of fat-containing lesions of the chest and describes the fat-suppression techniques utilized in their assessment.


  • Open Access

    Spontaneous elimination of a bronchial mucoid pseudotumor – A curious but pleasant surprise

    by P.P. Teixeira e Silva Torres, M. Fouad Rabahi, E. Marchiori